Ignite Creation Date:
2025-12-24 @ 6:36 PM
Ignite Modification Date:
2025-12-29 @ 1:41 PM
Study NCT ID:
NCT02226757
Status:
UNKNOWN
Last Update Posted:
2014-08-27
First Post:
2014-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients
Sponsor:
Amsterdam UMC, location VUmc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-06-02
First Submit QC Date:
None
Study First Post Date:
2014-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-25
Last Update Post Date:
2014-08-27
Last Update Post Date Type:
ESTIMATED